EDGAR Filing Documents for 0001193125-08-235158

Form 8-K - Current report:

SEC Accession No. 0001193125-08-235158

Filing Date

2008-11-13

Accepted

2008-11-13 16:09:36

Documents

Period of Report

2008-11-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	23293
2	FORM OF SENIOR SECURED PROMISSORY NOTE	dex41.htm	EX-4.1	32419
3	FORM OF COMMON STOCK PURCHASE WARRANT	dex42.htm	EX-4.2	77756
4	FORM OF NOTE AND WARRANT PURCHASE AGREEMENT	dex101.htm	EX-10.1	144052
5	SECURITY AGREEMENT	dex102.htm	EX-10.2	56940
6	PLACEMENT AGENCY AGREEMENT	dex103.htm	EX-10.3	64048
7	PRESS RELEASE ANNOUNCING THIRD QUARTER FINANCIAL RESULTS	dex991.htm	EX-99.1	57158
8	PRESS RELEASE ANNOUNCING FINANCING	dex992.htm	EX-99.2	10191
9	PRESS RELEASE ANNOUNCING NEW UROCOOL SYSTEM	dex993.htm	EX-99.3	20569
10	GRAPHIC	g51579g81z75.jpg	GRAPHIC	5890
	Complete submission text file	0001193125-08-235158.txt		496804

Mailing Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130

Business Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130 (858) 436-1000

Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33635 | Film No.: 081185105
SIC: 2836 Biological Products, (No Diagnostic Substances)